Saudi Arabia Takes Precautions to Continue to Contain Inflation

The inflation rate in Saudi Arabia remains at low levels. (Asharq Al-Awsat)
The inflation rate in Saudi Arabia remains at low levels. (Asharq Al-Awsat)
TT

Saudi Arabia Takes Precautions to Continue to Contain Inflation

The inflation rate in Saudi Arabia remains at low levels. (Asharq Al-Awsat)
The inflation rate in Saudi Arabia remains at low levels. (Asharq Al-Awsat)

Saudi Arabia has resumed its process of raising the repurchase agreement rate, “repo”, by 25 basis points to 6%, and increasing the reverse repurchase agreement rate by 25 basis points to 5.50%.

The move is part of the Kingdom’s efforts to reduce inflation, which currently stands at a relatively low and non-alarming level of 2.7%.

The decision by the Saudi Central Bank (SAMA) follows the approval by the US Federal Reserve on Wednesday to raise interest rates by 25 basis points, aligning with its objectives to maintain monetary stability.

SAMA had kept interest rates unchanged in June, in line with the US central bank's decision to pause its perceived opportunistic increase, allowing investors to take a breather and inject more investments into the local market.

Speaking to Asharq Al-Awsat, experts said the decision aids in transforming investments from quantitative to qualitative, as cautious funds migrate towards central banks.

They believe it contributes to monetary stability amidst the ongoing surge in global inflation, which consequently affects Saudi Arabia. The Kingdom has taken all necessary measures to curb the rise in inflation.

Saudi Shura Council member Fadel al-Buainain told Asharq Al-Awsat that interest rates are among the most crucial tools for controlling inflation or stimulating the economy, depending on economic variables and demands.

He emphasized that controlling interest rates will not achieve the desired goals unless there is harmony between fiscal and monetary policies, and a synchronization of their tools to achieve strategic objectives.

In al-Buainain’s view, what the US economy needs may not be the same for economies tied to the dollar, including Saudi Arabia and the Gulf countries. Nevertheless, they find themselves obliged to mirror the Federal Reserve’s actions to maintain monetary stability.

He explained that Gulf countries are not experiencing high inflation rates; in fact, they have some of the lowest. He stressed that inflation in Saudi Arabia remains at a relatively low and non-alarming level, while the economy requires stimulation to sustain growth.

Al-Buainain said that raising interest rates leads to a slowdown in economic growth and may negatively impact certain sectors and projects due to increased financing costs, especially in the real estate sector, which heavily relies on borrowing.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.